TORINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 22.862
AS - Asia 3.580
EU - Europa 3.037
SA - Sud America 480
AF - Africa 70
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 7
Totale 30.066
Nazione #
US - Stati Uniti d'America 22.717
SG - Singapore 1.516
IT - Italia 965
CN - Cina 692
BR - Brasile 396
HK - Hong Kong 364
RU - Federazione Russa 359
VN - Vietnam 348
DE - Germania 320
UA - Ucraina 306
IE - Irlanda 226
FI - Finlandia 189
FR - Francia 171
GB - Regno Unito 155
JP - Giappone 130
BD - Bangladesh 100
CA - Canada 94
NL - Olanda 91
KR - Corea 80
IN - India 69
ID - Indonesia 58
SE - Svezia 53
TR - Turchia 50
PL - Polonia 32
AR - Argentina 31
AT - Austria 28
AU - Australia 27
MX - Messico 27
BE - Belgio 26
CZ - Repubblica Ceca 26
TW - Taiwan 24
IR - Iran 19
ZA - Sudafrica 17
ES - Italia 16
EC - Ecuador 15
MY - Malesia 15
GR - Grecia 13
IQ - Iraq 13
NP - Nepal 13
PK - Pakistan 13
SA - Arabia Saudita 13
AL - Albania 12
CO - Colombia 12
PH - Filippine 12
CL - Cile 11
CH - Svizzera 10
EG - Egitto 10
TH - Thailandia 10
MA - Marocco 9
TN - Tunisia 9
DZ - Algeria 7
LT - Lituania 7
RO - Romania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
JM - Giamaica 6
PT - Portogallo 6
UZ - Uzbekistan 6
CR - Costa Rica 5
DK - Danimarca 5
NO - Norvegia 5
PY - Paraguay 5
AZ - Azerbaigian 4
GT - Guatemala 4
NG - Nigeria 4
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
KH - Cambogia 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
Totale 30.060
Città #
Woodbridge 5.943
Houston 5.081
Wilmington 5.041
Singapore 937
Fairfield 622
Chandler 592
Ashburn 514
Ann Arbor 448
San Jose 416
Council Bluffs 356
Hong Kong 347
Beijing 318
Rome 268
Seattle 262
Jacksonville 249
Dublin 215
Cambridge 206
New York 181
The Dalles 181
Medford 153
Santa Clara 129
Helsinki 115
Los Angeles 110
Dearborn 102
Tokyo 93
Hanoi 87
Buffalo 82
Milan 77
Lawrence 75
Ho Chi Minh City 72
Dallas 69
Lauterbourg 62
Moscow 62
Chicago 55
Redwood City 55
Boardman 54
Jakarta 43
Munich 43
San Diego 42
Dong Ket 39
Phoenix 39
São Paulo 39
London 31
Menlo Park 29
Mülheim 27
Nuremberg 27
North Bergen 25
Salt Lake City 25
Columbus 24
Montreal 24
Brooklyn 22
Nanjing 22
Warsaw 22
Brno 21
Brussels 21
Amsterdam 20
Naples 19
Toronto 19
Sanayi 18
Norwalk 17
Orem 17
Redondo Beach 17
Denver 16
Escondido 16
Lachine 16
New Kensington 16
University Park 16
Verona 15
Florence 14
Guangzhou 14
Taipei 14
Miami 13
Poplar 13
Vienna 13
Falls Church 12
Frankfurt am Main 12
Lappeenranta 12
Rio de Janeiro 12
Shanghai 12
Stockholm 12
Tampa 12
Zhengzhou 12
Istanbul 11
Johannesburg 11
Mountain View 11
Turin 11
Belo Horizonte 10
Boston 10
Da Nang 10
Hefei 10
Kathmandu 10
Manchester 10
Palermo 10
Bari 9
Chennai 9
Curitiba 9
Sydney 9
Bologna 8
Engelhard 8
Haiphong 8
Totale 24.767
Nome #
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 634
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 593
La mutualità nel caregiving: una revisione della letteratura 585
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 540
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 531
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 493
Thyroid dysfunction as an unintended side effect of anticancer drugs. 493
Focus on Fotemustine 492
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 489
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 489
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 485
Circulating tumor cells in colorectal cancer patients 485
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 476
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 467
Medullary thyroid cancer: a promising model for targeted therapy. 466
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 460
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 458
Endocrine side effects induced by immune checkpoint inhibitors. 456
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 456
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 454
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 454
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 451
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 446
Endocrinological side-effects of immune checkpoint inhibitors 443
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 442
Endocrine side effects induced by immune checkpoint inhibitors. 440
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 439
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 435
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 434
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 432
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 431
Mouse models of medullary thyroid cancer and developing new targeted therapies 430
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 427
Targeted therapy of breast cancer. 426
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 424
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 424
Therapy of breast cancer with molecular targeting agents. 421
Skin acrometastases in squamous cell carcinoma of the tongue. 416
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 416
Therapeutic agents that inhibit angiogenesis. 414
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 413
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 409
Genetic and molecular pathophysiology of medullary thyroid cancer. 403
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 399
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 399
Is tailored therapy feasible in oncology? 392
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 392
Tailored therapy of colorectal cancer: results, challenges and future directions. 389
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 378
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 377
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 375
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 369
Combination of antiangiogenic therapy with other anticancer treatment. 362
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 359
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 358
Molecular targeted therapy of medullary thyroid carcinoma 332
Gut microbiota and cancer: From pathogenesis to therapy 239
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 233
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 227
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 175
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 165
Validity and Reliability of the Self-Care of Chronic Illness Inventory and Self-Care Self-Efficacy Scale in Patients Living With Cancer 164
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 163
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 148
Development and content validity of the self-care of oral anticancer agents index 145
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 140
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 138
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 131
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 129
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 129
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 129
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 126
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 123
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 122
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 121
Psychometric Properties of the Self Care Oral Anticancer Agents Index (SCOAAI) 121
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 120
La Terza Missione dell'Università: formazione e salute 114
Describing self-care behaviours in cancer patients taking oral anticancer agents 114
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 114
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 113
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy 105
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 104
Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review 91
AMBRA1 and SQSTM1 expression pattern in prostate cancer 91
Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review 89
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 88
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 88
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 87
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 87
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma 86
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 86
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 86
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 85
CN29 Short term effects of self-care behaviours on quality of life for patients on oral anticancer agents 84
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 82
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 79
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 77
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions 66
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report 64
Totale 30.021
Categoria #
all - tutte 75.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 0 0 93
2021/2022922 44 74 41 50 35 71 47 43 53 109 64 291
2022/20231.438 137 154 130 158 107 267 82 93 116 23 125 46
2023/2024621 85 34 32 27 48 106 37 32 22 17 16 165
2024/20252.583 87 474 200 135 76 178 222 176 222 344 258 211
2025/20265.138 425 208 474 337 512 201 784 618 545 495 367 172
Totale 30.349